You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Taxol

Showing 1 - 25 of 920
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer Trial in Birmingham (Carboplatin, olaparibp, embro)

Not yet recruiting
  • Ovarian Cancer
  • Birmingham, Alabama
    O'Neal Comprehensive Cancer Center at UAB
Jul 18, 2023

Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage IIIA Uterine Corpus Cancer Trial in Canada,

Active, not recruiting
  • Endometrial Clear Cell Adenocarcinoma
  • +5 more
  • Baltimore, Maryland
  • +6 more
Apr 25, 2022

Gastric Cancer, Gastroesophageal Junction Cancer Trial in Seoul (afatinib, paclitaxel)

Completed
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System, Yonsei Canc
Jan 26, 2023

Adult Solid Tumor Trial in Chicago (Carboplatin, Laboratory Biomarker Analysis, Paclitaxel)

Active, not recruiting
  • Adult Solid Neoplasm
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jan 25, 2023

Serous Ovarian Cancer, Advanced Ovarian Cancer Trial (SC0191, Gemcitabine, Paclitaxel)

Not yet recruiting
  • Serous Ovarian Cancer
  • Advanced Ovarian Cancer
  • (no location specified)
Sep 20, 2023

Esophageal Cancer Trial in Calgary (Carboplatin and Taxol (paclitaxel), External Beam Radiation)

Recruiting
  • Esophageal Cancer
  • Carboplatin and Taxol (paclitaxel)
  • External Beam Radiation
  • Calgary, Alberta, Canada
    Tom Baker Cancer Centre
Mar 23, 2022

Gastric Adenocarcinoma, Carcinomatosis Trial in Houston (Paclitaxel, Dexamethasone, Diphenhydramine)

Not yet recruiting
  • Gastric Adenocarcinoma
  • Carcinomatosis
  • Houston, Texas
    M D Anderson Cancer Center
Aug 7, 2023

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) Trial in Pittsburgh (Pembrolizumab, Carboplatin,

Not yet recruiting
  • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 18, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +3 more
  • Biopsy
  • +4 more
  • (no location specified)
Jan 4, 2023

Esophagus Cancer Trial in Guangzhou (Cadonilimab, Paclitaxel and cisplatin, intensity-modulated radiotherapy)

Not yet recruiting
  • Esophagus Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University
Nov 20, 2023

Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Epithelial Ovarian Cancer Trial in Baltimore (procedure, drug, other)

Recruiting
  • Stage III Ovarian Cancer
  • +6 more
  • Cytoreductive Surgery (CRS)
  • +6 more
  • Baltimore, Maryland
    Mercy Medical Center
Aug 30, 2022

Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial (Biopsy, Biospecimen Collection, Computed Tomography)

Not yet recruiting
  • Metastatic Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Biopsy
  • +5 more
  • (no location specified)
Nov 8, 2022

Locally Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy,

Not yet recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Nov 8, 2022

Ovarian Cancer Trial in Milwaukee (Pembrolizumab, Carboplatin, Paclitaxel)

Active, not recruiting
  • Ovarian Cancer
  • Milwaukee, Wisconsin
    Medical College of Wisconsin and Froedtert Hospital
Apr 7, 2022

Triple-negative Breast Cancer Trial (Pembrolizumab 25 mg/ml, Paclitaxel injection)

Not yet recruiting
  • Triple-negative Breast Cancer
  • Pembrolizumab 25 mg/ml
  • Paclitaxel injection
  • (no location specified)
Oct 11, 2023

Endometrial Cancer, Endometrial Adenocarcinoma Trial in United States (Pembrolizumab, Paclitaxel, Carboplatin)

Completed
Has Results
  • Endometrial Cancer
  • Endometrial Adenocarcinoma
  • Mesa, Arizona
  • +5 more
Feb 17, 2022

Advanced Cancer Trial in Houston (Temsirolimus, Bevacizumab, Paclitaxel)

Active, not recruiting
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 11, 2022

Metastatic Pancreatic Carcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Rochester (Cisplatin, Hyperthermic Intraperitoneal

Not yet recruiting
  • Metastatic Pancreatic Carcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 6, 2023

Stage IIIB NSCLC AJCC v7, Stage IV NSCLC AJCC v7 Trial in Portland (Laboratory Biomarker Analysis, Paclitaxel, Pharmacological

Completed
  • Stage IIIB Non-Small Cell Lung Cancer AJCC v7
  • Stage IV Non-Small Cell Lung Cancer AJCC v7
  • Laboratory Biomarker Analysis
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 14, 2022

Triple Negative Breast Cancer Trial in Dhaka (Doxorubicin, Cyclophosphamide, Paclitaxel)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Dhaka, Bangladesh
    Bangabandhu Sheikh Mujib Medical University
May 24, 2023

Endometrial Cancer Trial (MK-2870, Doxorubicin, Paclitaxel)

Not yet recruiting
  • Endometrial Cancer
  • MK-2870
  • +2 more
  • (no location specified)
Nov 10, 2023

Kaposi Sarcoma, HIV-1-infection Trial (Pegylated liposomal doxorubicin, Paclitaxel)

Not yet recruiting
  • Kaposi Sarcoma
  • HIV-1-infection
  • (no location specified)
Jan 20, 2023

Lung Cancer Trial in Tampa, Columbus (Carboplatin, Paclitaxel, AZD1775)

Active, not recruiting
  • Lung Cancer
  • Tampa, Florida
  • +1 more
Feb 2, 2023

Endometrial Cancer Trial in Houston (Paclitaxel, Carboplatin, Dostarlimab)

Not yet recruiting
  • Endometrial Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Apr 6, 2023

Advanced Solid Tumor Trial in Bronx, Portland, Dallas (BAL0891, Carboplatin, Paclitaxel)

Recruiting
  • Advanced Solid Tumor
  • Bronx, New York
  • +2 more
Mar 19, 2023